- Product Description Description
- Table of Contents TOC
- List of Table & Figure LOT
- Get Free Sample PDF Sample PDF
Executive Summary: Middle East and Africa Metabolomics Market
- Market Scope: Comprehensive regional analysis of the Middle East and Africa (MEA) metabolomics market covering analytical product categories, medical indications, functional applications, country-level breakdowns, and key industry participants.
- Market Valuation: Valued at USD 512.69 million in 2025, estimated at USD 640.86 million in 2026, and projected to reach USD 3,819.82 million by 2034, registering a rapid CAGR of 25% during the forecast period from 2026 to 2034.
- Primary Growth Drivers: Emerging recognition and integration of metabolomics in personalized medicine, expanding biotechnology R&D investments, rising pharmaceutical consumption, and untapped growth opportunities across emerging economies in the MEA region. Key market restraints include a shortage of qualified and precisely trained specialists.
Key Market Segment Metrics (2026–2034)
| Category | Leading Segment (2025 Position) | Fastest-Growing Segment |
|---|---|---|
| By Product | Mass Spectrometry & HPLC / UPLC (dominant analytical share in metabolite detection and profiling) | Bioinformatics & Surface-Based Mass Analysis (scaling with advanced data analytics requirements) |
| By Indication | Oncology (primary clinical application driving biomarker research and personalized therapies) | Cardiology & Inborn Errors of Metabolism |
| By Application | Drug Discovery & Biomarker Identification (core revenue contributors for pharmaceutical R&D) | Nutrigenomics & Toxicology |
| By Country / Region | KSA, UAE & Israel (leading regional hubs backed by advanced healthcare infrastructure and investments) | South Africa, Egypt & Rest of MEA Emerging Markets |
Major Market Players & Market Structure
Market Structure: A specialized, high-tech regional market driven by global analytical instrumentation companies, bioinformatics providers, and specialized contract research laboratories supporting life sciences and clinical research.
Key Companies: Afekta Technologies Ltd., MS-OMICS ApS, Metabolomic Technologies Inc., Creative Proteomics, Metware Biotechnology Co., Ltd., Scion Instruments, Genedata AG, Kore Technology Ltd., DANI Instruments S.p.A., GL Sciences, Inc., JASCO Corporation, Phenomenex, Inc., Diagnostic Solutions Laboratory, VProteomics, and Metabolomics Australia.
Middle East and Africa Metabolomics Market Size
The Middle East and Africa metabolomics market size was valued at USD 512.69 million in 2025 and is anticipated to reach USD 640.86 million in 2026 from USD 3819.82 million by 2034, growing at a CAGR of 25% during the forecast period from 2026 to 2034.
Metabolomics is the significant scale research of little molecules, generally known as metabolites, inside cells, biofluids, tissues, or living beings. Metabolomics is a proficient approach since metabolites and their concentration, not like other "omics" measures, straightforwardly reflect the unseen biochemical movement and tissues' condition. Consequently, metabolomics signifies atomic phenotype. Aggregately, these little atoms and their associations inside an organic framework are known as the metabolome.
The emerging recognition of metabolomics in customized medicines is one of the key factors boosting the market's growth. The expanding biotech innovative work and pharmaceutical consumption prompt persistent headways in innovation, spelling development for the worldwide metabolomics market. The unexplored markets in rising countries will goad new development open doors for market players. Further, the requirement for precisely qualified specialists and the lack of the same is limiting the expansion of the metabolomics market. The Middle East and Africa's Metabolomics market are evolving at a rapid speed.
KEY MARKET PLAYERS
Some of the promising companies that are playing a dominating role in the Middle East and Africa Metabolomics Market include
- Afekta Technologies Ltd.
- MS-OMICS ApS
- Metabolomic Technologies Inc.
- Creative Proteomics
- Metware Biotechnology Co., Ltd.
- Scion Instruments
- Genedata AG
- Kore Technology Ltd.
- DANI Instruments S.p.A.
- GL Sciences, Inc.
- JASCO Corporation
- Phenomenex, Inc.
- Diagnostic Solutions Laboratory
- VProteomics
- Metabolomics Australia
MARKET SEGMENTATION
This research report on the Middle East and Africa Metabolomics Market has been segmented and sub-segmented into the following categories.
By Product
- GC
- Bioinformatics
- Mass Spectrometry
- HPLC
- UPLC
- NMRS
- Surface-based mass analysis
By Indication
- Oncology
- Cardiology
- Inborn Error
By Application
- Nutrigenomics
- Toxicology
- Biomarker
- Drug Discovery
By Country
- KSA
- UAE
- Israel
- the rest of GCC countries
- South Africa
- Ethiopia
- Kenya
- Egypt
- Sudan
- rest of MEA